BELLEROPHON THERAPEUTICS INC's ticker is BLPH and the CUSIP is 078771102. A total of 25 filers reported holding BELLEROPHON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $17,000 | -32.0% | 36,429 | -12.2% | 0.00% | – |
| Q2 2019 | $25,000 | +13.6% | 41,494 | +22.9% | 0.00% | – |
| Q1 2019 | $22,000 | -26.7% | 33,773 | -9.2% | 0.00% | – |
| Q4 2018 | $30,000 | -21.1% | 37,208 | +6.0% | 0.00% | – |
| Q3 2018 | $38,000 | +40.7% | 35,109 | +217.5% | 0.00% | – |
| Q2 2018 | $27,000 | -25.0% | 11,058 | -35.5% | 0.00% | – |
| Q1 2018 | $36,000 | +100.0% | 17,149 | +33.0% | 0.00% | – |
| Q3 2017 | $18,000 | -87.3% | 12,894 | -16.4% | 0.00% | – |
| Q1 2015 | $142,000 | – | 15,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEW MOUNTAIN VANTAGE ADVISERS, L.L.C. | 4,859,885 | $11,955,000 | 0.64% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $246,000 | 0.00% |
| Alyeska Investment Group, L.P. | 143,985 | $354,000 | 0.00% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 31,792 | $78,000 | 0.00% |
| Geneva Advisors, LLC | 12,500 | $31,000 | 0.00% |
| BlackRock Investment Management, LLC | 846 | $2,000 | 0.00% |
| MORGAN STANLEY | 500 | $1,000 | 0.00% |
| BlackRock Institutional Trust Company, N.A. | 28,379 | $70,000 | 0.00% |
| Walleye Trading LLC | 700 | $2,000 | 0.00% |
| LPL Financial LLC | 61,246 | $131,000 | 0.00% |